Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1995 Aug;48(8):693–700. doi: 10.1136/jcp.48.8.693

ACP Broadsheet No 146: August 1995. Macroscopic examination of prostatic specimens.

P Harnden 1, M C Parkinson 1
PMCID: PMC502791  PMID: 7560191

Full text

PDF
693

Images in this article

695Image
on p.695
697Image
on p.697

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allsbrook W. C., Jr, Simms W. W. Histochemistry of the prostate. Hum Pathol. 1992 Mar;23(3):297–305. doi: 10.1016/0046-8177(92)90111-f. [DOI] [PubMed] [Google Scholar]
  2. Bastacky S. I., Walsh P. C., Epstein J. I. Relationship between perineural tumor invasion on needle biopsy and radical prostatectomy capsular penetration in clinical stage B adenocarcinoma of the prostate. Am J Surg Pathol. 1993 Apr;17(4):336–341. doi: 10.1097/00000478-199304000-00003. [DOI] [PubMed] [Google Scholar]
  3. Blute M. L., Zincke H., Farrow G. M. Long-term followup of young patients with stage A adenocarcinoma of the prostate. J Urol. 1986 Oct;136(4):840–843. doi: 10.1016/s0022-5347(17)45098-1. [DOI] [PubMed] [Google Scholar]
  4. Bostwick D. G. Gleason grading of prostatic needle biopsies. Correlation with grade in 316 matched prostatectomies. Am J Surg Pathol. 1994 Aug;18(8):796–803. doi: 10.1097/00000478-199408000-00006. [DOI] [PubMed] [Google Scholar]
  5. Bostwick D. G., Graham S. D., Jr, Napalkov P., Abrahamsson P. A., di Sant'agnese P. A., Algaba F., Hoisaeter P. A., Lee F., Littrup P., Mostofi F. K. Staging of early prostate cancer: a proposed tumor volume-based prognostic index. Urology. 1993 May;41(5):403–411. doi: 10.1016/0090-4295(93)90497-x. [DOI] [PubMed] [Google Scholar]
  6. Bova G. S., Fox W. M., Epstein J. I. Methods of radical prostatectomy specimen processing: a novel technique for harvesting fresh prostate cancer tissue and review of processing techniques. Mod Pathol. 1993 Mar;6(2):201–207. [PubMed] [Google Scholar]
  7. Brawer M. K., Deering R. E., Brown M., Preston S. D., Bigler S. A. Predictors of pathologic stage in prostatic carcinoma. The role of neovascularity. Cancer. 1994 Feb 1;73(3):678–687. doi: 10.1002/1097-0142(19940201)73:3<678::aid-cncr2820730329>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
  8. Cantrell B. B., DeKlerk D. P., Eggleston J. C., Boitnott J. K., Walsh P. C. Pathological factors that influence prognosis in stage A prostatic cancer: the influence of extent versus grade. J Urol. 1981 Apr;125(4):516–520. doi: 10.1016/s0022-5347(17)55092-2. [DOI] [PubMed] [Google Scholar]
  9. Catalona W. J., Richie J. P., Ahmann F. R., Hudson M. A., Scardino P. T., Flanigan R. C., deKernion J. B., Ratliff T. L., Kavoussi L. R., Dalkin B. L. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men. J Urol. 1994 May;151(5):1283–1290. doi: 10.1016/s0022-5347(17)35233-3. [DOI] [PubMed] [Google Scholar]
  10. Cheng C. W., Bergstralh E. J., Zincke H. Stage D1 prostate cancer. A nonrandomized comparison of conservative treatment options versus radical prostatectomy. Cancer. 1993 Feb 1;71(3 Suppl):996–1004. doi: 10.1002/1097-0142(19930201)71:3+<996::aid-cncr2820711417>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
  11. Del Rosario A. D., Bui H. X., Abdulla M., Ross J. S. Sulfur-rich prostatic intraluminal crystalloids: a surgical pathologic and electron probe x-ray microanalytic study. Hum Pathol. 1993 Nov;24(11):1159–1167. doi: 10.1016/0046-8177(93)90210-8. [DOI] [PubMed] [Google Scholar]
  12. Ellis D. W., Leffers S., Davies J. S., Ng A. B. Multiple immunoperoxidase markers in benign hyperplasia and adenocarcinoma of the prostate. Am J Clin Pathol. 1984 Mar;81(3):279–284. doi: 10.1093/ajcp/81.3.279. [DOI] [PubMed] [Google Scholar]
  13. Epstein J. I., Carmichael M. J., Pizov G., Walsh P. C. Influence of capsular penetration on progression following radical prostatectomy: a study of 196 cases with long-term followup. J Urol. 1993 Jul;150(1):135–141. doi: 10.1016/s0022-5347(17)35415-0. [DOI] [PubMed] [Google Scholar]
  14. Epstein J. I., Carmichael M., Walsh P. C. Adenocarcinoma of the prostate invading the seminal vesicle: definition and relation of tumor volume, grade and margins of resection to prognosis. J Urol. 1993 May;149(5):1040–1045. doi: 10.1016/s0022-5347(17)36291-2. [DOI] [PubMed] [Google Scholar]
  15. Epstein J. I., Oesterling J. E., Eggleston J. C., Walsh P. C. Frozen section detection of lymph node metastases in prostatic carcinoma: accuracy in grossly uninvolved pelvic lymphadenectomy specimens. J Urol. 1986 Dec;136(6):1234–1237. doi: 10.1016/s0022-5347(17)45295-5. [DOI] [PubMed] [Google Scholar]
  16. Epstein J. I., Pizov G., Walsh P. C. Correlation of pathologic findings with progression after radical retropubic prostatectomy. Cancer. 1993 Jun 1;71(11):3582–3593. doi: 10.1002/1097-0142(19930601)71:11<3582::aid-cncr2820711120>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  17. Epstein J. I., Walsh P. C., Carmichael M., Brendler C. B. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. JAMA. 1994 Feb 2;271(5):368–374. [PubMed] [Google Scholar]
  18. Foucar E., Haake G., Dalton L., Pathak D. R., Lujan J. P. The area of cancer in transurethral resection specimens as a prognostic indicator in carcinoma of the prostate: a computer-assisted morphometric study. Hum Pathol. 1990 Jun;21(6):586–592. doi: 10.1016/s0046-8177(96)90003-9. [DOI] [PubMed] [Google Scholar]
  19. Fudge K., Wang C. Y., Stearns M. E. Immunohistochemistry analysis of platelet-derived growth factor A and B chains and platelet-derived growth factor alpha and beta receptor expression in benign prostatic hyperplasias and Gleason-graded human prostate adenocarcinomas. Mod Pathol. 1994 Jun;7(5):549–554. [PubMed] [Google Scholar]
  20. Greene D. R., Wheeler T. M., Egawa S., Weaver R. P., Scardino P. T. Relationship between clinical stage and histological zone of origin in early prostate cancer: morphometric analysis. Br J Urol. 1991 Nov;68(5):499–509. doi: 10.1111/j.1464-410x.1991.tb15394.x. [DOI] [PubMed] [Google Scholar]
  21. Hall G. S., Kramer C. E., Epstein J. I. Evaluation of radical prostatectomy specimens. A comparative analysis of sampling methods. Am J Surg Pathol. 1992 Apr;16(4):315–324. doi: 10.1097/00000478-199204000-00001. [DOI] [PubMed] [Google Scholar]
  22. Humphrey P. A., Walther P. J. Adenocarcinoma of the prostate. I. Tissue sampling considerations. Am J Clin Pathol. 1993 Jun;99(6):746–759. doi: 10.1093/ajcp/99.6.746. [DOI] [PubMed] [Google Scholar]
  23. Humphrey P. A., Walther P. J. Adenocarcinoma of the prostate. Part II: Tissue prognosticators. Am J Clin Pathol. 1993 Sep;100(3):256–269. doi: 10.1093/ajcp/100.3.256. [DOI] [PubMed] [Google Scholar]
  24. Lepor H. Medical therapy for benign prostatic hyperplasia. Urology. 1993 Nov;42(5):483–501. doi: 10.1016/0090-4295(93)90258-c. [DOI] [PubMed] [Google Scholar]
  25. Loda M., Fogt F., French F. S., Posner M., Cukor B., Aretz H. T., Alsaigh N. Androgen receptor immunohistochemistry on paraffin-embedded tissue. Mod Pathol. 1994 Apr;7(3):388–391. [PubMed] [Google Scholar]
  26. Markham C. W. Prostatic intraepithelial neoplasia: detection and correlation with invasive cancer in fine-needle biopsy. Urology. 1989 Dec;34(6 Suppl):57–61. [PubMed] [Google Scholar]
  27. McDonnell T. J., Troncoso P., Brisbay S. M., Logothetis C., Chung L. W., Hsieh J. T., Tu S. M., Campbell M. L. Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Res. 1992 Dec 15;52(24):6940–6944. [PubMed] [Google Scholar]
  28. McDowell P. R., Fox W. M., Epstein J. I. Is submission of remaining tissue necessary when incidental carcinoma of the prostate is found on transurethral resection? Hum Pathol. 1994 May;25(5):493–497. doi: 10.1016/0046-8177(94)90121-x. [DOI] [PubMed] [Google Scholar]
  29. McKelvie G. B., Collins G. N., Hehir M., Rogers A. C. A study of benign prostatic hyperplasia--a challenge to British urology. Br J Urol. 1993 Jan;71(1):38–42. doi: 10.1111/j.1464-410x.1993.tb15877.x. [DOI] [PubMed] [Google Scholar]
  30. McNeal J. E. Cancer volume and site of origin of adenocarcinoma in the prostate: relationship to local and distant spread. Hum Pathol. 1992 Mar;23(3):258–266. doi: 10.1016/0046-8177(92)90106-d. [DOI] [PubMed] [Google Scholar]
  31. Moore G. H., Lawshe B., Murphy J. Diagnosis of adenocarcinoma in transurethral resectates of the prostate gland. Am J Surg Pathol. 1986 Mar;10(3):165–169. doi: 10.1097/00000478-198603000-00002. [DOI] [PubMed] [Google Scholar]
  32. Murphy W. M., Dean P. J., Brasfield J. A., Tatum L. Incidental carcinoma of the prostate. How much sampling is adequate? Am J Surg Pathol. 1986 Mar;10(3):170–174. doi: 10.1097/00000478-198603000-00003. [DOI] [PubMed] [Google Scholar]
  33. Navone N. M., Troncoso P., Pisters L. L., Goodrow T. L., Palmer J. L., Nichols W. W., von Eschenbach A. C., Conti C. J. p53 protein accumulation and gene mutation in the progression of human prostate carcinoma. J Natl Cancer Inst. 1993 Oct 20;85(20):1657–1669. doi: 10.1093/jnci/85.20.1657. [DOI] [PubMed] [Google Scholar]
  34. Newman A. J., Jr, Graham M. A., Carlton C. E., Jr, Lieman S. Incidental carcinoma of the prostate at the time of transurethral resection: importance of evaluating every chip. J Urol. 1982 Nov;128(5):948–950. doi: 10.1016/s0022-5347(17)53293-0. [DOI] [PubMed] [Google Scholar]
  35. Parkinson M. C., Fisher C. ACP Broadsheet 130: November 1991. Gross examination of bladder specimens. J Clin Pathol. 1991 Nov;44(11):890–895. doi: 10.1136/jcp.44.11.890. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Rohr L. R. Incidental adenocarcinoma in transurethral resections of the prostate. Partial versus complete microscopic examination. Am J Surg Pathol. 1987 Jan;11(1):53–58. doi: 10.1097/00000478-198701000-00007. [DOI] [PubMed] [Google Scholar]
  37. Sadi M. V., Barrack E. R. Image analysis of androgen receptor immunostaining in metastatic prostate cancer. Heterogeneity as a predictor of response to hormonal therapy. Cancer. 1993 Apr 15;71(8):2574–2580. doi: 10.1002/1097-0142(19930415)71:8<2574::aid-cncr2820710823>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
  38. Schröder F., Tribukait B., Böcking A., DeVere White R., Koss L., Lieber M., Stenkvist B., Zetterberg A. Clinical utility of cellular DNA measurements in prostate carcinoma. Consensus Conference on Diagnosis and Prognostic Parameters in Localized Prostate Cancer. Stockholm, Sweden, May 12-13, 1993. Scand J Urol Nephrol Suppl. 1994;162:51–27. [PubMed] [Google Scholar]
  39. Shah I. A., Schlageter M. O., Stinnett P., Lechago J. Cytokeratin immunohistochemistry as a diagnostic tool for distinguishing malignant from benign epithelial lesions of the prostate. Mod Pathol. 1991 Mar;4(2):220–224. [PubMed] [Google Scholar]
  40. Srigley J. R., Dardick I., Hartwick R. W., Klotz L. Basal epithelial cells of human prostate gland are not myoepithelial cells. A comparative immunohistochemical and ultrastructural study with the human salivary gland. Am J Pathol. 1990 Apr;136(4):957–966. [PMC free article] [PubMed] [Google Scholar]
  41. Thomas D. J., Robinson M., King P., Hasan T., Charlton R., Martin J., Carr T. W., Neal D. E. p53 expression and clinical outcome in prostate cancer. Br J Urol. 1993 Nov;72(5 Pt 2):778–781. doi: 10.1111/j.1464-410x.1993.tb16267.x. [DOI] [PubMed] [Google Scholar]
  42. Umbas R., Schalken J. A., Aalders T. W., Carter B. S., Karthaus H. F., Schaafsma H. E., Debruyne F. M., Isaacs W. B. Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer. Cancer Res. 1992 Sep 15;52(18):5104–5109. [PubMed] [Google Scholar]
  43. Vollmer R. T. Prostate cancer and chip specimens: complete versus partial sampling. Hum Pathol. 1986 Mar;17(3):285–290. doi: 10.1016/s0046-8177(83)80221-4. [DOI] [PubMed] [Google Scholar]
  44. di Sant'Agnese P. A. Neuroendocrine differentiation in carcinoma of the prostate. Diagnostic, prognostic, and therapeutic implications. Cancer. 1992 Jul 1;70(1 Suppl):254–268. doi: 10.1002/1097-0142(19920701)70:1+<254::aid-cncr2820701312>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES